Biotech startup EnGeneIC, has raised the maximum $5 million allowable under Australian crowd-sourced funding (CSF) law. It's just the second time a CSF campaign has maxed out, following on from Zero Co's $5 million raise, which took just six hours, in mid-October. The EnGeneIC raise took place on VentureCrowd, initially with a $1 million target... Read more »
EnGeneIC is an Australia-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer and infectious diseases.